ArticleCancer chemotherapy and pharmacology2025

A novel Ondansetron extended release injectable suspension (OERIS): evaluation of Safety, tolerability and pharmacokinetics in a phase I trial.

Veerendra Kumar Panuganti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.